You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
瑞銀:中概股或已調整過度,多數ADR有資格在香港第二上市 阿斯達克財經 · 4分鐘前

來源:阿斯達克財經

就美國證監會(SEC)上週根據《外國公司問責法》將5家中概股公司納入「預摘牌名單」,對中概股退市風險的擔憂瞬間傳導到市場。

瑞銀髮表中國市場策略報告表示,消息導致在美上市的中概股於過去兩個交易日股價挫20%,瑞銀對市場相關沽壓感到驚訝,顯示投資者情緒低迷,從宏觀數據和企業最近的盈利預測下調也可能導致下跌,但料隨着內地政府刺激措施推出、企業未來盈利可迎回升勢頭,將可爲預測未來一年市盈率估值已處八年低位的MSCI中國指數帶來支持,認爲市場拋售已過度。

瑞銀指,機構投資者似乎是今次中概股主要賣家,但大型的中概股已大多在香港雙重上市,投資者可以輕鬆地將其持有的ADR轉換爲H股,而因授權限制不能轉換ADR爲H股的相信只佔整體ADR的3-5%。

瑞銀指,對於已作雙重上市的中概股,近三個月機構投資者對相關中概股的ADR所有權下降了2.6個百分點,但同時,機構投資者在香港上市部份持股增加0.9個百分點,表明部分投資者已將其ADR轉換爲H股。從港交所中央結算系統數據也顯示,雙重上市公司的香港上市部分已從流通股的48%增加到53%,而轉換大多在$京東(JD.US)$$京東集團-SW(09618.HK)$、$阿裏巴巴(BABA.US)$$阿裏巴巴-SW(09988.HK)$和$理想汽車(LI.US)$$理想汽車-W(02015.HK)$發生。

瑞銀表示,多數的ADR(52家公司佔ADR總市值的96%,包括20家已經雙重上市的公司)目前有資格在香港第二上市。此外,香港證券交易所和監管機構正在討論可能放寬未通過盈利測試的「科技創新」公司上市規則。假設最終要求與適用於生物技術公司的要求相似(市值超過15億港元),料可新增約 41家中國ADR公司(相當於佔中國ADR總市值2%)可能有資格在香港上市。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account